CASI - CASI Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue---47.712
Cost of Revenue---6.274
Gross Profit---41.438
Operating Expenses
Research Development7,714.3777,110.1824,317.563,673.572
Selling General and Administrative18,790.0693,641.1385,103.053,520.269
Non Recurring----
Others----
Total Operating Expenses26,504.44610,751.329,420.617,200.115
Operating Income or Loss-26,504.446-10,751.32-9,420.61-7,152.403
Income from Continuing Operations
Total Other Income/Expenses Net-967.122-18.882-32.878-54.02
Earnings Before Interest and Taxes-26,504.446-10,751.32-9,420.61-7,152.403
Interest Expense-8.208-14.976-33.808-82.455
Income Before Tax-27,471.568-10,770.202-9,453.488-7,206.423
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-27,471.568-10,770.202-9,453.488-7,206.423
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-27,471.568-10,770.202-9,453.488-7,206.423
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-27,471.568-10,770.202-9,453.488-7,206.423